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ABSTRACT 
We sequenced and compared the complete genomes of 22 strains of 
coronavirus HKU1 (CoV-HKU1) obtained from nasopharyngeal aspirates of patients 
with respiratory tract infections over a two-year period. Phylogenetic analysis of 24 
putative proteins and polypeptides showed that the 22 CoV-HKU1 strains fell into 
three clusters (genotype A, 13 strains; genotype B, three strains and genotype C, six 
strains). However, different phylogenetic relationships among the three clusters were 
observed in different regions of their genomes. From nsp4 to nsp6, the genotype A 
strains were clustered with the genotype B strains. For nsp7 and nsp8, and from nsp10 
to nsp16, the genotype A strains were clustered with the genotype C strains. From 
hemagglutinin esterase (HE) to nucleocapsid (N), the genotype B strains were 
clustered closely with the genotype C strains. Bootscan analysis showed possible 
recombination between genotypes B and C from nucleotide positions 11500 to 13000, 
corresponding to the nsp6/nsp7 junction, giving rise to genotype A; and between 
genotypes A and B from nucleotide positions 21500 to 22500, corresponding to the 
nsp16/HE junction, giving rise to genotype C. Multiple alignments further narrowed 
the sites of cross-over to a 143-bp region between nucleotide positions 11750 and 
11892, and a 29-bp region between nucleotide positions 21502 and 21530. Genome 
analysis also revealed variable numbers of tandem copies of a perfect 30-base acidic 
tandem repeat (ATR) which encodes NDDEDVVTGD and variable numbers and 
sequences of imperfect repeats in the N-terminal of nsp3 inside the acidic domain 
upstream of papain-like protease 1 among the 22 genomes. All 10 CoV-HKU1 with 
incomplete imperfect repeats (1.4 and 4.4) belonged to genotype A. The present study 
represents the first evidence for natural recombination in coronavirus associated with 
human infection. Analysis of a single gene is not sufficient for genotyping of CoV-
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HKU1, but would require amplification and sequencing of at least two gene loci, one 
from nsp10 to nsp16 (e.g pol or helicase) and another from HE to N (e.g spike or N). 
Further studies will delineate whether the ATR is useful for molecular typing of CoV-
HKU1. 
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INTRODUCTION 
The recent severe acute respiratory syndrome (SARS) epidemic, the discovery 
of SARS coronavirus (SARS-CoV) and the identification of SARS-CoV-like viruses 
from Himalayan palm civets and a raccoon dog from wild live markets in mainland 
China have led to a boost in interests in the discovery of novel coronaviruses in both 
humans and animals (8, 23, 26, 28, 40, 42). In 2004, a novel group 1 human 
coronavirus, human coronavirus NL63 (HCoV-NL63) was reported independently by 
two groups (6, 34). In 2005, we described the discovery, complete genome sequence, 
clinical features and molecular epidemiology of a novel group 2 human coronavirus, 
coronavirus HKU1 (CoV-HKU1, genotype A) (17, 37-39, 41). This virus has also 
been subsequently found in patients with respiratory tract infections in other countries 
(1, 30, 35). Recently, we have also identified a SARS-CoV-like virus in Chinese 
horseshoe bats and a novel group 1 coronavirus in large bent-winged bats, lesser bent-
winged bats and Japanese long-winged bats in Hong Kong Special Administrative 
Region (HKSAR) (16, 27). The discovery of SARS-CoV-like viruses in horseshoe 
bats was confirmed by another group in other provinces in China (19).  
As a result of the unique mechanism of viral replication, coronaviruses have a 
high frequency of recombination (15). Their tendency for recombination and high 
mutation rates may allow them to adapt to new hosts and ecological niches. However, 
no convincing evidence of genetic recombination has been documented among human 
coronaviruses which may have contributed to their ability of human re-infection. In 
our study on phylogeny of the RNA-dependent RNA polymerase (pol), spike (S) and 
nucleocapsid (N) genes of nine isolates of CoV-HKU1 recovered from patients with 
pneumonia, it was discovered that the sequences of the S and N genes fell into two 
distinct genotypes, with seven strains belonging to genotype A and two belonging to 
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genotype B (41). On the other hand, for the pol gene, one of the two “genotype B” 
strains by the S and N sequences (from patient 8) was clustered with the other seven 
“genotype A” strains (41). Furthermore, the same phenomenon was also observed in 
our subsequent prospective study on CoV-HKU1 associated respiratory tract 
infections (17). Based on these observations, we suspected that there is an additional 
CoV-HKU1 genotype which has arisen from recombination between genotypes A and 
B of CoV-HKU1. 
To test this hypothesis, we performed complete genome sequencing on 21 
additional strains of CoV-HKU1 and compared their genomes to the CoV-HKU1 
genotype A strain (38). The sites of recombination were identified and a novel CoV-
HKU1 genotype, genotype C, was defined. 
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MATERIALS AND METHODS 
CoV-HKU1 strains. All 22 CoV-HKU1 strains were isolated from patients 
with respiratory tract infections in Hong Kong in a two-year period (March 2003 – 
February 2005) (Table 1) (17, 38, 41).  
RNA extraction. Viral RNA was extracted from the nasopharyngeal aspirates 
of the patients using QIAamp Viral RNA Mini Kit (QIAgen, Hilden, Germany). The 
RNA pellet was resuspended in 10 μl of DNase-free, RNase-free double-distilled 
water and was used as the template for RT-PCR. 
Complete genome sequencing and genome analysis. The complete genome 
sequence of the CoV-HKU1 genotype A strain was described previously (GenBank 
accession no. NC_006577) (38). The complete genomes of the other 21 CoV-HKU1 
strains were amplified and sequenced using the RNA extracted from the 
nasopharyngeal aspirates of the corresponding patients as template, using a strategy 
described previously (38). The RNA was converted to cDNA by a combined random-
priming and oligo(dT) priming strategy. The 5’ ends of the viral genomes were 
confirmed by rapid amplification of cDNA ends using the 5'/3' RACE kit (Roche, 
Germany). Sequences were assembled and manually edited to produce final 
sequences of the viral genomes. The 21 genomes were compared to that of the CoV-
HKU1 genotype A strain and were manually annotated.  
Phylogenetic tree construction. The nucleotide sequences of nsp1, nsp2, 
conserved portions of nsp3 [including papain-like protease 1 (PL1pro), Appr-1-p 
processing enzyme family (A1pp), papain-like protease 2 (PL2pro) and hydrophobic 
domain (HD)], nsp4-nsp10, nsp12-nsp16, hemagglutinin esterase (HE), S, ORF4, 
envelope (E), membrane (M) and N were extracted from the 22 CoV-HKU1 genomes. 
Phylogenetic tree construction was performed using neighbor joining method with 
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ClustalX 1.83. The corresponding nucleotide sequences of human coronavirus OC43 
(HCoV-OC43) (GenBank accession no. AY585229) were used as outgroups.  
Bootscan analysis. To perform bootscan analysis, a nucleotide alignment of 
the genome sequences of one genotype A (38), one genotype B (Patient 1 of Ref 41) 
and one genotype C (Patient 8 of Ref 41) strain of CoV-HKU1 and one HCoV-OC43 
(GenBank accession no. AY585229) was generated by ClustalX version 1.83 and 
edited manually. Bootscan analysis was performed using Simplot version 3.5.1 (20) 
(F84 model; window size, 1000 bp; step, 200 bp) with the genome sequence of 
HCoV-OC43 as a query.  
Nucleotide sequence accession number. The nucleotide sequences of the 21 
additional genomes of CoV-HKU1 have been lodged within the GenBank sequence 
database under accession no. AY884001, DQ339101, DQ415896, DQ415897, 
DQ415898, DQ415899, DQ415900, DQ415901, DQ415902, DQ415903, DQ415904, 
DQ415905, DQ415906, DQ415907, DQ415908, DQ415909, DQ415910, DQ415911, 
DQ415912, DQ415913 and DQ415914. 
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RESULTS 
Complete genome sequence, genome organization, phylogenetic analysis 
and genotypes. The sizes of the genomes of the 22 CoV-HKU1 strains ranged from 
29295 to 30097 nucleotides. The G + C contents of all 22 genomes are 32%. The 
overall genome organizations of the 22 CoV-HKU1 strains were the same (Fig. 1A).  
Phylogenetic trees using the nucleotide sequences of putative proteins and 
polypeptides [nsp1, nsp2, conserved portions of nsp3 (PL1pro, A1pp, PL2pro and HD), 
nsp4-nsp10, nsp12-nsp16, HE, S, ORF4, E, M and N] of the 22 CoV-HKU1 were 
constructed and shown in Fig. 1B. In 18 of the 24 trees, the 22 CoV-HKU1 strains fell 
clearly into three clusters, named as genotype A (13 strains), genotype B (three strains) 
and genotype C (six strains). The exceptions are the five trees constructed using nsp1, 
nsp2, PL1pro, PL2pro and HD in which the differences among the sequences were too 
small and the nsp10 tree in which two genotype A strains, N1 and N3, were clustered 
with genotype C strains.  
The three genotypes exhibited different relationships to each other in different 
regions of their genomes. From nsp4 to nsp6, the genotype A strains were clustered 
with the genotype B strains, but for nsp7 and nsp8, the genotype A strains were 
clustered with the genotype C strains. From nsp10 to nsp16, the genotype A strains 
were clustered closely with the genotype C strains with high bootstrap values, but 
from HE to N, the genotype B strains were clustered closely with the genotype C 
strains, with bootstrap values of 1000 in all cases. No association was observed 
between the genotypes and the time of detection or the age, sex, clinical disease, 
presence of underlying disease and outcome of the patients (Table 1). 
The putative transcription regulatory sequence (TRS) motif, 5’-
AAUCUAAAC-3’ [as in mouse hepatitis virus (MHV) and bovine coronavirus] (22), 
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or alternatively, 5’-UAAAUCUAAAC-3’, that was found at the 3’ end of the leader 
sequence and precedes each translated ORF except ORF5 described in the genome of 
the CoV-HKU1 genotype A strain, was also present in all the other 21 CoV-HKU1 
genomes. On the other hand, the sequence of the putative internal ribosomal entry site 
(IRES) (32) for the ORF of the envelope protein in the genomes of all three CoV-
HKU1 genotype B strains and all six genotype C CoV-HKU1 strains were 
UUUUAUCGCUUGG, instead of AUUUAUUGUUUGG in all 13 CoV-HKU1 
genotype A strains, although both sequences were similar to the IRES element, 
UUUUAUUCUUUUU, in MHV (10). 
The 22 genomes differed in the number of tandem copies of the 30-base acidic 
tandem repeat (ATR) in the N-terminal of nsp3 inside the acidic domain upstream of 
PL1pro (Tables 1 and 2). All 22 genomes had tandem copies of a perfect 30-base 
repeat which encodes NDDEDVVTGD and variable numbers of imperfect repeats. 
The median number of tandem copies of the perfect 30-base repeat was 11.5 (range 2-
17) and the median number of imperfect repeat was 2 (range 1-4). All the 10 CoV-
HKU1 with incomplete imperfect repeats (1.4 and 4.4) belonged to genotype A.  
 Bootscan analysis. Bootscan analysis showed that from the 5’ end of the 
genome to position 12000, there could be a number of possible recombination sites in 
the genomes of the three genotypes (Fig. 2). Right upstream to position 11500, high 
bootstrap support for clustering between the CoV-HKU1 genotype A strain and the 
CoV-HKU1 genotype B strain was observed. From positions 13000 to 21500, high 
bootstrap support for clustering between the CoV-HKU1 genotype A strain and the 
CoV-HKU1 genotype C strain was observed. From position 22500 to the 3’ end of the 
genome, high bootstrap support for clustering between the CoV-HKU1 genotype B 
strain and CoV-HKU1 genotype C strain was observed. These indicate that 
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recombination has possibly taken place between nucleotide positions 11500 and 
13000, corresponding to the nsp6/nsp7 junction, and between nucleotide positions 
21500 and 22500, corresponding to the nsp16/HE junction. 
 Comparative sequence analysis of the nsp6/nsp7 junction and nsp13/HE 
gene junction. Since both phylogenetic trees and bootscan analysis showed that there 
was a possible recombination site at the nsp6/nsp7 junction and the nsp16/HE gene 
junction, multiple alignments among the nucleotide sequences of the 22 genomes 
were performed to ascertain the exact sites of recombination.  
Upstream to nucleotide position 11750 of the CoV-HKU1 genotype A genome 
(227 bases before the end of nsp6), there was high nucleotide identity between the 
sequences of the CoV-HKU1 genotype A and genotype B strains, whereas 
downstream to nucleotide position 11892 of the CoV-HKU1 genotype A genome (85 
bases before the end of nsp6), there was high nucleotide identity between the 
sequences of the CoV-HKU1 genotype A and genotype C strains (Fig. 3). This 
indicates that the site of cross-over was probably within a 143-bp region between 
nucleotide positions 11750 and 11892. 
Upstream to nucleotide position 21502 of the CoV-HKU1 genotype A genome 
(249 bases before the stop codon of ORF1ab), there was high nucleotide identity 
between the sequences of the CoV-HKU1 genotype A and genotype C strains, 
whereas downstream to nucleotide position 21530 of the CoV-HKU1 genotype A 
genome (221 bases before the stop codon of ORF1ab), there was high nucleotide 
identity between the sequences of the CoV-HKU1 genotype B and genotype C strains, 
including a 13-bp insertion just downstream to the stop codon of ORF1ab (Fig. 4). 
This indicates that the site of cross-over was probably within a 29-bp region between 
nucleotide positions 21502 and 21530. 
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DISCUSSION 
This is the first time that evidence for natural coronavirus recombination is 
documented in coronavirus associated with human infection. Coronaviruses are 
unique in having high frequency of homologous RNA recombination, as a result of 
random template switching during RNA replication, thought to be mediated by a 
“copy-choice” mechanism (2, 4, 13, 14, 21, 33). In feline coronavirus (FCoV), it has 
been documented that FCoV type II strains originated from a double recombination 
between FCoV type I and canine coronavirus, and the site of recombination has been 
pinpointed to a region of about 50 nucleotides in the M gene by multiple alignment 
(9). As for recombination between different strains of MHV, in vitro studies have 
shown variations in both sites and rates of recombination, with the S gene having a 
frequency three fold that of the polymerase gene (7, 21). In the present study, by 
comparing the sequences of 22 complete genomes of CoV-HKU1, we documented 
that major recombination has occurred among the three CoV-HKU1 genotypes. Both 
phylogenetic and bootscan analysis showed that the nucleotide sequences of the six 
genotype C strains were almost identical to those of the 13 genotype A strains from 
nsp10 to nsp16 (Fig. 1B and 4). Interestingly, the topologies of the phylogenetic trees 
changed dramatically starting from the HE gene. From HE to N, the nucleotide 
sequences of the six genotype C strains were almost identical to those of the three 
genotype B strains (Fig. 1B). This is also in line with results of bootscan analysis, 
suggesting recombination between genotypes A and B, giving rise to genotype C (Fig. 
2). Multiple alignments of the nucleotide sequences of the nsp16/HE regions of the 
three genotypes confirmed our suspicion and results localized the site of 
recombination to a stretch of 29 nucleotides in nsp16, just  upstream to the stop codon 
of ORF1ab (Fig. 4). This is in keeping with the finding that the putative IRES of all 
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the genotype B and genotype C strains were the same, but different from those of the 
genotype A strains, as it is located downstream to HE. In addition to the 
recombination site in nsp16, there was another one at the end of nsp6, also evidenced 
by a shift in clustering in the phylogenetic trees, bootscan analysis and multiple 
alignments results (Fig. 1B, 2 and 3). In contrast to the nsp16 recombination site, 
recombination has occurred between genotypes B and C in this region, giving rise to 
genotype A. Furthermore, as shown in bootscan and phylogenetic analysis, additional 
recombination events might have occurred in ORF1ab upstream to nsp5 (Fig. 1B and 
2). However, due to the relatively small variations in the sequence among the three 
genotypes, these putative recombination sites were difficult to ascertain by multiple 
alignments. 
A novel genotype, genotype C, of CoV-HKU1 is defined. It has been well 
known that recombination is an important mechanism for the generation and 
evolution of virus genotypes (12, 29, 31). In our previous study, we showed that seven 
of the nine CoV-HKU1 strains were of genotype A and one of the nine strains were of 
genotype B by pol, S and N gene sequence analysis (41). In the present study, we 
showed that the latter half of the genomes of the six genotype C strains probably 
represent a result of recombination between genotypes A and B. Analysis of the 
complete genomes of more CoV-HKU1 strains from other countries will reveal the 
relative prevalence of the different genotypes in different localities. From the results 
of the present study, no association was observed between the genotypes and clinical 
characteristics of the patients. Furthermore, amplification and sequencing of a single 
gene is not sufficient to define the genotype of CoV-HKU1. It would require 
amplification and sequencing of at least two gene loci, one from nsp10 to nsp16 (e.g 
pol or helicase) and another from HE to N (e.g S or N). 
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The origin and function of the ATR located inside the acidic domain upstream 
of PL1pro, unique to CoV-HKU1, remain enigmatic. Significant variations were 
observed among the ATR of CoV-HKU1 strains. Only two pairs of CoV-HKU1 
strains (N1 and N3, N7 and N9) possessed the same nucleotide sequence in the ATR. 
No relationship was found between the number of repeats and the genotype or 
virulence of the strains. We speculate that this “independent evolution” of the number 
of repeats was due to the random expansion or deletion of part of the repeat region 
during the process of viral replication as a result of inaccurate replication by the viral 
polymerase or recombination between the repeat regions of different CoV-HKU1, a 
phenomenon widely observed in tandem repeats of genomes in all domains of life (3, 
24). On the other hand, the sequence of the imperfect repeats seemed to co-evolve 
with the rest of the genomes, most notably that all 10 CoV-HKU1 strains with 
incomplete imperfect repeats (NDDD) were of genotype A (Tables 1 and 2). This 
could be due to the deletion of part of a repeat in one genotype A strain, and 
subsequent expansion or deletion of whole repeats in its descendents. Further studies 
will delineate whether this ATR is useful for molecular typing of CoV-HKU1. 
This high frequency of recombination has resulted in the generation of a high 
diversity of coronaviruses in different animals. Before the SARS epidemic in 2003, a 
total of 19 coronaviruses were known, including two human, 13 mammalian and four 
avian coronaviruses. After the SARS epidemic, within a short period of three years, 
20 additional novel coronaviruses were described (5, 6, 11, 16, 19, 25, 26, 34, 36, 38, 
43). These include three human coronaviruses, 11 mammalian coronaviruses and six 
avian coronaviruses. Notably the recent discovery of at least eight different species of 
coronaviruses in bats in Hong Kong, including SARS-CoV-like viruses and a 
probable novel subgroup, group 2c, of coronavirus (16, 43). The high frequency of 
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recombination in such a high diversity of coronaviruses may easily result in the 
generation of novel coronavirus species or genotypes that can cross host species 
barriers, leading to major zoonotic outbreaks with disastrous consequences. The 
potential of generation of novel species leading to zoonotic outbreaks and major 
consequences is analogous to the situation of avian and human influenza 
epidemiology, although the mechanism of generation of novel types and variants is by 
reassortment, which is different from recombination in coronaviruses (18, 44). 
Amplification of conserved regions in coronaviruses using RNA extracted from 
various animal specimens will lead to the discovery of more coronaviruses and 
subsequent complete genome sequencing and comparative genome analysis will 
reveal the intricate relationships among the various coronaviruses.  
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LEGENDS TO FIGURES 
FIG. 1. Genome organization and phylogenetic analysis of CoV-HKU1. (A) 
Genome organization of CoV-HKU1. The regions of the genome used for 
phylogenetic tree construction are labeled. (B) Phylogenetic analysis of nsp1, nsp2, 
conserved portions of nsp3 (PL1pro, A1pp, PL2pro and HD), nsp4-10, nsp12-16, HE, S, 
ORF4, E, M and N of the 22 CoV-HKU1 genomes. The trees were constructed by 
neighbor joining method using Jukes-Cantor correction and bootstrap values 
calculated from 1000 trees. 740, 1821, 655, 333, 895, 1263, 1488, 909, 861, 276, 582, 
330, 411, 2783, 1809, 1563, 1125, 900, 1276, 4126, 330, 253, 687, 1358 nucleotide 
positions in nsp1, nsp2, PL1pro, A1pp, PL2pro, HD, nsp4, nsp5, nsp6, nsp7, nsp8, nsp9, 
nsp10, nsp12, nsp13, nsp14, nsp15, nsp16, HE, S, ORF4, E, M and N respectively 
were included in the analysis. The scale bar indicates the estimated number of 
substitutions per 50 or 100 nucleotides as indicated. The corresponding nucleotide 
sequences of HCoV-OC43 were used as the outgroups. A, genotype A; B, genotype B 
and C, genotype C. 
FIG. 2. Bootscan analysis of the CoV-HKU1 genomes. Bootscanning was 
conducted with Simplot version 3.5.1 (F84 model; window size, 1000 bp; step, 200 bp) 
on a gapless nucleotide alignment, generated with ClustalX, with the genome 
sequence of HCoV-OC43 (AY585229) as the query sequence. The dashed line 
denotes the CoV-HKU1 genotype A (NC_006577), the solid line denotes the CoV-
HKU1 genotype B (AY884001) and the dotted line denotes the CoV-HKU1 genotype 
C (DQ339101). 
FIG. 3. Comparative sequence analysis of the nsp6/nsp7 junction. Multiple 
alignment of the nucleotide sequences of CoV-HKU1 genotypes A, B and C. In CoV-
HKU1 genotype B and CoV-HKU1 genotype C, only the nucleotides differing from 
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those in CoV-HKU1 genotype A are depicted. The nucleotides in CoV-HKU1 
genotype C that are the same as those in CoV-HKU1 genotype A but different from 
those in CoV-HKU1 genotype B are highlighted in black, and those in CoV-HKU1 
genotype B that are the same as those in CoV-HKU1 genotype A but different from 
those in CoV-HKU1 genotype C are highlighted in gray. The putative template 
switching region is underlined and bolded. The first (TCA) and last (CAG) codons of 
nsp7 are also underlined. The arrows denote positions with nucleotide polymorphism 
[at 11414, N16, N17, N20, N21 and N22 (genotype C) were T instead of C; at 11422, 
N16 and N20 (genotype C) was C instead of T; at 11449, N25 (genotype B) was C 
instead of T; at 11528, N16, N17, N20 and N22 (genotype C) was C instead of T; at 
11740, N6, N7, N9, N10, N11, N13, N14, N18, N23 and N24 (genotype A) was T 
instead of C; at 12095, N6 and N7 (genotype A) was T instead of C; at 12140, N23 
and N24 (genotype A) was C instead of T; and 12367, N15 and N25 (genotype C) 
was A instead of G; and at 12400, N6, N7, N9, N10, N11, N13, N14, N18, N23 and  
N24 (genotype A) was C instead of T]. 
FIG. 4. Comparative sequence analysis of the nsp16/HE gene junction. 
Multiple alignment of the nucleotide sequences of CoV-HKU1 genotypes A, B and C. 
In CoV-HKU1 genotype A and CoV-HKU1 genotype B, only the nucleotides 
differing from those in CoV-HKU1 genotype C are depicted. The nucleotides in CoV-
HKU1 genotype C that are the same as those in CoV-HKU1 genotype A but different 
from those in CoV-HKU1 genotype B are highlighted in gray, and those in CoV-
HKU1 genotype C that are the same as those in CoV-HKU1 genotype B but different 
from those in CoV-HKU1 genotype A are highlighted in black. The putative template 
switching region is underlined and bolded. The stop codon of ORF1ab (TAG) and the 
start codon of the HE gene (ATG) are also underlined. The arrows denote positions 
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with nucleotide polymorphism [at 21297, N6, N7, N9, N10, N11, N13, N14, N23 and 
N24 (genotype A) were T instead of G; at 21429, N6 (genotype A) was C instead of T; 
at 21576, N15 (genotype B) was C instead of T; at 21908, N15 and N25 (genotype B) 
was G instead of A; and at 21949, N14 was T instead of C]. 
 
TABLE 1. Characteristics of the 22 CoV-HKU1 strains used in this study 
 
Strain no. Source Month/Year of 
detection 
Patient characteristics CoV-HKU1 characteristics 
   Sex Age Upper/lower respiratory 
tract infection 
Underling disease Clinical outcome Genotype No. of NDDEDVVTGD 
repeats 
No. of imperfect 
repeats 
N2 Patient 1 in ref 41 Mar/03 F 35 Lower Absent Survived B 11 2 
N3 Patient 2 in ref 41 Apr/03 M 66 Lower Present Died A 14 2 
N1 Patient 5 in ref 41 Jan/04 M 71 Lower Present Survived A 14 2 
N5 Patient 8 in ref 41 Jan/04 M 68 Lower Absent Survived C 8 3 
N6 Unpublished Jan/04 F 29 Upper Present Survived A 2 1.4 
N7 Patient 4 in ref 41 Jan/04 M 75 Lower Present Survived A 12 1.4 
N9 Patient 9 in ref 41 Mar/04 F 83 Lower Present Survived A 12 1.4 
N10 Patient 10 in ref 41 Mar/04 M 72 Lower Present Died A 13 1.4 
N11 Patient 1 in ref 17 Apr/04 F 2 Upper Absent Survived A 15 1.4 
N13 Patient 2 in ref 17 May/04 F 7 Upper Present Survived A 9 1.4 
N14 Patient 3 in ref 17 Jul/04 M 84 Upper Present Survived A 10 1.4 
N15 Patient 4 in ref 17 Nov/04 M 3 Upper Present Survived B 15 1 
N16 Patient 5 in ref 17 Nov/04 M 87 Lower Present Survived C 10 4 
N17 Patient 6 in ref 17 Nov/04 F 4 Upper Present Survived C 10 2 
N18 Patient 7 in ref 17 Nov/04 M 2 Lower Absent Survived A 13 1.4 
N19 Patient 8 in ref 17 Dec/04 M 19 Upper Absent Survived A 11 3 
N20 Patient 9 in ref 17 Dec/04 M 3 Upper Absent Survived C 10 4 
N21 Patient 10 in ref 17 Dec/04 F 9 Upper Present Survived C 10 3 
N22 Patient 11 in ref 17 Jan/05 F 3 Upper Absent Survived C 13 3 
N24 Patient 12 in ref 17 Jan/05 M 5 Upper Present Survived A 17 4.4 
N23 Patient 13 in ref 17 Feb/05 M 4 Upper Present Survived A 11 1.4 
N25 Unpublished Feb/05 F 5 months Upper Absent Survived B 12 2 
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TABLE 2. Amino acid sequences of acidic tandem repeats of the 22 CoV-HKU1 strains 
 
Genotypes 
and strain 
no. 
Amino acid sequences 
Genotype A  
 N1 (NDDEDVVTGD)14(NNDEEIVTGD)(NDDQIVVTGD) 
 N3 (NDDEDVVTGD)14(NNDEEIVTGD)(NDDQIVVTGD) 
 N6 (NDDEDVVTGD)2(NDDD)(NDDQIVVIGD) 
 N7 (NDDEDVVTGD)12(NDDD)(NDDQIVVIGD) 
 N9 (NDDEDVVTGD)12(NDDD)(NDDQIVVIGD) 
 N10 (NDDEDVVTGD)13(NDDD)(NDDQIVVIGD) 
 N11 (NDDEDVVTGD)15(NDDD)(NDDQIVVIGD) 
 N13 (NDDEDVVTGD)9(NDDD)(NDDQIVVIGD) 
 N14 (NDDEDVVTGD)10(NDDD)(NDDQIVVIGD) 
 N18 (NDDEDVVTGD)13(NDDD)(NDDQIVVIGD) 
 N19 (NDDEDVVTGD)10(NNDEEIVTGD)(NDDEDVVTGD)1(NNDEEIVTGD)(NDDQIVVTGD) 
 N23 (NDDEDVVTGD)11(NDDD)(NDDQIVVIGD) 
 N24 (NDDEDVVTGD)1(NDDEHVVTGD)(NDDEHVVTGD)(NDDEDVVTGD)9(NDDEHVVTGD)(NDDEDVVTGD)7(NDDD)(NDDQIVVIGD) 
Genotype B  
 N2 (NDDEDVVTGD)11(NDDEEIVTGD)(NDDQIVVTGD) 
 N15 (NDDEDVVTGD)15(ND-QIVVTGD) 
 N25 (NDDEDVVTGD)12(NDDEEIVTGD)(NDDQIVVTGD) 
Genotype C  
 N5 (NDDEDVVTGD)8(NNDEDVVTGD)(NNDEESVTGD)(NDDQIVVTGD) 
 N16 (NDDEDVVTGD)10(NNDEDVVTGD)(NNGEDVVTGD)(NNDEESVTGD)(NDDQIVVTGD) 
 N17 (NDDEDVVTGD)10(NNDEESVTGD)(NDDQIVVTGD) 
 N20 (NDDEDVVTGD)10(NNDEDVVTGD)(NNGEDVVTGD)(NNDEESVTGD)(NDDQIVVTGD) 
 N21 (NDDEDVVTGD)10(NNDEDVVTGD)(NNDEESVTGD)(NDDQIVVTGD) 
 N22 (NDDEDVVTGD)13(NNDEDVVTGD)(NNDEESVTGD)(NDDQIVVTGD) 
The amino acids underlined denote those that are different from the NDDEDVVTGD tandem repeats. 
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                                ↓       ↓                          ↓ 
Genotype C  ................T...C.C.............................G.......  11297 
Genotype A  TTACTTATGTCTGGCTCTCATATTTTGTTCCTGCTGTGAATTTTACTTATGTTTATGAAG  11453 
Genotype B  ............................................................  11357 
 
Genotype C  ............................................................  11357 
Genotype A  TATTTTATGGTTGTATTTTATGTGTTTTTGCTATTTTTATAACTATGCATAGTATTAATC  11513 
Genotype B  ............................................................  11417 
                          ↓ 
Genotype C  .........................A..................................  11417 
Genotype A  ATGACATTTTTTCTTTGATGTTTTTGGTTGGTAGAATAGTTACTTTAATTTCTATGTGGT  11573 
Genotype B  ............................................................  11477 
 
Genotype C  .......T....................................................  11477 
Genotype A  ATTTTGGGTCGAATTTAGAAGAGGATGTTTTGTTATTTATTACAGCCTTTTTAGGTACTT  11633 
Genotype B  ............................................................  11537 
 
Genotype C  ......................G.....................................  11537 
Genotype A  ATACATGGACCACTATTTTGTCATTAGCTATAGCAAAAATTGTTGCTAATTGGTTGTCTG  11693 
Genotype B  ............................................................  11597 
                                                          ↓ 
Genotype C  ............................C........G.................T....  11597 
Genotype A  TTAATATATTTTATTTTACAGATGTACCTTATATTAAATTGATTCTCTTGAGTTACTTAT  11753 
Genotype B  ..............................................T.............  11657 
 
Genotype C  ............................................................  11657 
Genotype A  TTATAGGGTATATTTTATCTTGTTATTGGGGATTTTTCTCTCTTTTAAACAGTGTTTTTA  11813 
Genotype B  ............................................................  11717 
 
Genotype C  ............................................................  11717 
Genotype A  GAATGCCTATGGGTGTTTATAATTATAAAATTTCTGTTCAAGAATTGCGTTATATGAATG  11873 
Genotype B  ............................................................  11777 
 
Genotype C  ........................................................T...  11777 
Genotype A  CTAATGGCTTACGTCCACCTCGTAATAGTTTTGAGGCTATTTTGTTAAATTTAAAACTGC  11933 
Genotype B  ...................C........................................  11837 
 
Genotype C  ............................................................  11837 
Genotype A  TTGGAATAGGTGGCGTGCCAGTTATTGAAGTCTCCCAAATTCAATCAAAATTGACTGATG  11993 
Genotype B  ...............................T..T.........................  11897 
 
Genotype C  ............................................................  11897 
Genotype A  TGAAATGTGCTAATGTTGTTTTGTTAAATTGTTTACAGCATTTGCATGTTGCTTCTAATT  12053 
Genotype B  ............................................................  11957 
                                                     ↓ 
Genotype C  ............................................................  11957 
Genotype A  CTAAGTTGTGGCAGTATTGTAGTGTTTTACATAATGAAATACTATCTACTTCAGATTTGA  12113 
Genotype B  ...G...................A..................................A.  12017 
                                      ↓ 
Genotype C  ............................................T...............  12017 
Genotype A  GTGTAGCTTTTGATAAGCTTGCTCAATTATTGATTGTTTTATTCGCCAATCCTGCTGCAG  12173 
Genotype B  ............................................................  12077 
 
Genotype C  ............................................................  12077 
Genotype A  TTGATACTAAGTGTCTTGCAAGTATAGATGAAGTTAGCGATGATTATGTTCAAGATAGTA  12233 
Genotype B  ............................................................  12137 
 
Genotype C  ............................................................  12137 
Genotype A  CCGTTTTGCAGGCTTTGCAAAGTGAGTTTGTAAATATGGCTAGTTTTGTTGAATATGAAG  12293 
Genotype B  .T..........................................................  12197 
 
Genotype C  ............................................................  12197 
Genotype A  TCGCAAAGAAAAATTTGGCTGATGCTAAAAATAGTGGTTCTGTTAATCAACAACAGATAA  12353 
Genotype B  ............................................................  12257 
                         ↓                                ↓ 
Genotype C  ..............................................C.............  12257 
Genotype A  AACAGTTAGAAAAAGCATGTAATATAGCTAAGTCTGTGTATGAACGTGATAAAGCTGTAG  12413 
Genotype B  .............G................................C.............  12317 
 FIG. 4. 
Genotype A  .............................................C..............  21182 
Genotype C  ATCTGGTAGTATTCTTGTAGATAATGATTTAAACCCATTTGTTAGTGATAGTTTAGTTAC  21026 
Genotype B  .................................T..T....................C..  21086 
 
 
Genotype A  ............................................................  21242 
Genotype C  TTATTTTGGAGATTGTATGACTTTACCATTTGATTGTCATTGGGATTTGATAATATCTGA  21086 
Genotype B  ..............................................C.............  21146 
 
                                                                  ↓ 
Genotype A  ......................................................G.....  21302 
Genotype C  TATGTATGATCCTCTTACTAAAAATATTGGTGATTATAATGTGAGTAAGGATGGTTTTTT  21146 
Genotype B  .....................G...................................C..  21206 
 
 
Genotype A  ............................................................  21362 
Genotype C  TACTTACATTTGTCATTTAATTCGTGATAAATTATCTTTGGGTGGTAGTGTAGCTATAAA  21206 
Genotype B  ......T......T.....................................T........  21266 
 
 
Genotype A  ............................................................  21422 
Genotype C  AATTACAGAGTTTTCTTGGAATGCTGATTTATATAAATTAATGAGTTGTTTTGCATTTTG  21266 
Genotype B  .........A.................C...................A.........C..  21326 
 
                  ↓ 
Genotype A  ............................................................  21482 
Genotype C  GACAGTTTTTTGTACTAATGTAAATGCTTCTTCTAGTGAAGGGTTTTTAATAGGTATAAA  21326 
Genotype B  ............................................................  21386 
 
 
Genotype A  ................................................T...........  21542 
Genotype C  TTACCTGGGTAAATCTTCTTTTGAAATAGATGGCAATGTTATGCATGCCAACTATTTGTT  21386 
Genotype B  ...TT.......G..C.GC.........................................  21446 
 
                                             ↓ 
Genotype A  ...........................C................................  21602 
Genotype C  TTGGAGAAATAGTACAACATGGAATGGTGGTGCTTATAGTTTATTTGATATGACTAAATT  21446 
Genotype B  ....................................................T.......  21506 
 
 
Genotype A  ...........................T..T.......................T.....  21662 
Genotype C  TTCTTTGAAATTGGCTGGCACTGCTGTAGTAAATTTAAGACCAGATCAATTAAACGATTT  21506 
Genotype B  ......................................................T.....  21566 
 
 
Genotype A  ......T....................A........T..C..............G.....  21722 
Genotype C  AGTTTACTCTCTTATTGAAAGAGGTAAGTTATTAGTGCGTGATACGCGTAAAGAAATTTT  21566 
Genotype B  ......T.....................................................  21626 
 
 
Genotype A  .....................T.............-------------C...........  21769 
Genotype C  TGTTGGTGATAGTCTTGTAAACACTTGTTAGATCTTTCAGTTTGTTAATATTAAATCTAA  21626 
Genotype B  ............................................................  21686 
 
 
Genotype A  ..............T............T....C.....................C.T...  21829 
Genotype C  ACTATGTTAATTATATTTTTATTTTTTAATTTTTGTTATGGTTTTAATGAACCTTTGAAT  21686 
Genotype B  ............................................................  21746 
 
 
Genotype A  ............................................................  21889 
Genotype C  GTTGTGTCTCATTTAAACCATGACTGGTTTTTATTTGGTGATAGTCGTTCTGATTGTAAC  21746 
Genotype B  ............................................................  21806 
 
                              ↓                                        ↓ 
Genotype A  ............................T..A...............C...........C  21949 
Genotype C  CATATTAATAATTTAAAAATTAAAAATTATGGTTATTTGGATATTCATCCTAGTTTGTGT  21806 
Genotype B  ...............................................C............  21866 
